Wednesday, September 14, 2022 10:47:13 PM
As we know, Portage was a reverse merge into Bontan corp. owned by the Robinson brothers… they were the founding partners along with Billionaire’s Dr. Bailey and Jim Mellon.. so who else was in on it?… ..John Robinson, brother and M2Bio investor Sheldon was among some of the chosen few who got in early… check it out..
Current Capital is owned 100% by Mr. John Robinson. Mr. Robinson is a selling shareholder with respect to 4,444,000 shares and 1,040,000 warrant shares owned by Current Capital Corp. Mr. Robinson owns 18% of our outstanding capital stock as of September 30, 2006. Current Capital is a media relations company and provides services to us
5
Sheldon Inwentash (5)
130 King Street West, Suite 2810
Toronto, ON M5X 1A9
Canada
7,612,000
25.12%
6,000,000
-
-
14
John D. Robinson (14)
47 Avenue Road, Suite 200
Toronto, ON M5R 2G3
Canada
5,545,199
18%
4,440,000
https://docoh.com/filing/1095435/0001168981-06-000043/PRTG-F3
The point is that this same template is being used here. They will manage the share structure, they will raise the funds that they need in a PP to the chosen few . Then they will build another Biotech Giant with NeuraiLife Sciences and spin out the other companies. At what point will the good Dr. B and J.M. step up?
Here is another clue,,,
?? Upcoming Events:
MASTER INVESTOR SECTOR FOCUS:
Going for Gold
Join us on 21st September for a webinar focused on gold. With global uncertainty has come a renewed interest in the precious metal and we’ll discuss the gold outlook with major investor, Jim Mellon. Master Investor will host four gold companies with exciting projects in development to help keep our investors ahead of the curve.
21 September 2022 | London | 1:30pm – 3:30pm
https://internetbullreport.com/the-weekly-bull-report-september-11-2022-??/
Looks like Jeff will be traveling again very soon to see his buddy Jim..
Recent MRES News
- M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board • InvestorsHub NewsWire • 07/19/2023 01:18:56 PM
- M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal Benefits • InvestorsHub NewsWire • 07/14/2023 12:52:00 PM
- M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access • InvestorsHub NewsWire • 07/06/2023 01:38:23 PM
- Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing • InvestorsHub NewsWire • 07/05/2023 02:04:17 PM
- M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX • InvestorsHub NewsWire • 06/26/2023 12:45:19 PM
- M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines • InvestorsHub NewsWire • 06/16/2023 12:30:00 PM
- M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for Commercialization • InvestorsHub NewsWire • 06/14/2023 12:00:00 PM
- Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions • InvestorsHub NewsWire • 06/07/2023 02:06:41 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM